FAKTOR-OPTIONSSCHEIN - PFIZER INC | Real-time Boerse Frankfurt Warrants 08:59:59 29/05/2024 BST | ||
| 4.52 EUR | -0.22% |
|
| Current month | +19.53% | ||
| 1 month | +21.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 4.52 | -0.22% |
| 28/05/24 | 4.53 | -4.83% |
| 27/05/24 | 4.76 | +0.85% |
| 24/05/24 | 4.72 | -0.21% |
| 23/05/24 | 4.73 | -4.44% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 08:59 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SB01FZ |
| ISIN | DE000SB01FZ9 |
| Date issued | 09/06/2020 |
| Strike | 35.94 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 25.47 € |
|---|---|
| Lowest since issue | 3.68 € |
| Spread | 0.04 € |
| Spread % | 0.88% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3
USD
Average target price
31.92
USD
Spread / Average Target
+12.78%
- Stock Market
- Certificates
- Certificat
